VERACYTE, INC.
For the period ended Dec 31, 2025. Filed Feb 26, 2026.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2025 · Filed Feb 26, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 15. Exhibits, Financial Statement Schedules
ITEM 15. EXHIBITS AND FINANCIAL STATEMENT SCHEDULES
(a)Documents filed as part of this report
- Financial Statements:
Reference is made to the Financial Statements and Supplementary Data included in Item 8 of Part II hereof.
- Financial Statement Schedules
All schedules have been omitted because they are not required, not applicable, or the required information is included in the financial statements or notes thereto.
- Exhibits
A list of exhibits to this Annual Report on Form 10-K is set forth below and is incorporated herein by reference. See Item 15(b) below. Each management contract or compensating plan or arrangement required to be filed has been identified.
(b)Exhibits
| Incorporated by Reference | ||||||
|---|---|---|---|---|---|---|
| Exhibit Number | Description | Form | File No. | Exhibit | Filing Date | Filed Herewith |
| 3.1 | Restated Certificate of Incorporation of the Registrant | 8-K | 001-36156 | 3.2 | 6/9/2023 | |
| 3.2 | Amended and Restated Bylaws of the Registrant | 8-K | 001-36156 | 3.3 | 6/9/2023 | |
| 4.1 | Form of Common Stock Certificate | S-1/A | 333-191282 | 4.1 | 10/15/2013 | |
| 4.2 | Description of Securities Registered under Section 12 of the Securities Exchange Act of 1934, as amended | X | ||||
| 10.1# | Form of Indemnification Agreement between the Registrant and its officers and directors | S-1/A | 333-191282 | 10.1 | 10/7/2013 | |
| 10.2# | 2013 Stock Incentive Plan, as amended, and forms of stock option award agreement, stock option exercise agreement, restricted stock agreement and restricted stock unit agreement | 8-K | 001-36156 | 10.1 | 3/3/2021 | |
| 10.3# | Form of stock option award under 2013 Stock Incentive Plan | 10-Q | 001-36156 | 10.1 | 11/2/2020 | |
| 10.4# | Form of stock unit award under 2013 Stock Incentive Plan | 10-Q | 001-36156 | 10.1 | 11/2/2020 | |
| 10.5# | Amended and Restated Employee Stock Purchase Plan | 10-Q | 001-36156 | 10.1 | 7/30/2020 | |
| 10.6# | Form of Performance Stock Unit | 10-Q | 001-36156 | 10.1 | 5/1/2018 | |
| 10.7† | License and Asset Purchase Agreement, dated December 3, 2019, between NanoString Technologies, Inc. and the Registrant | 8-K | 001-36156 | 2.1 | 12/3/2019 | |
| Incorporated by Reference | ||||||
|---|---|---|---|---|---|---|
| Exhibit Number | Description | Form | File No. | Exhibit | Filing Date | Filed Herewith |
| 10.8# | Employment Agreement, dated as of May 7, 2021, between Marc Stapley and the Registrant | 10-Q | 001-36156 | 10.2 | 7/29/2021 | |
| 10.9# | Change in Control and Severance Agreement, effective June 1, 2021 between Marc Stapley and the Registrant | 10-Q | 001-36156 | 10.3 | 7/29/2021 | |
| 10.10# | Amended and Restated Offer Letter, dated August 15, 2021, between the Registrant and Rebecca Chambers | 10-Q | 001-36156 | 10.1 | 11/9/2021 | |
| 10.11# | Change in Control and Severance Agreement, effective July 19, 2021 between Rebecca Chambers and the Registrant | 10-Q | 001-36156 | 10.2 | 11/9/2021 | |
| 10.12# | Offer Letter, dated as of January 9, 2023, between Annie McGuire and the Registrant | 10-K | 001-36156 | 10.32 | 3/1/2023 | |
| 10.13# | Change of Control and Severance Agreement, effective January 1, 2023, between Annie McGuire and the Registrant | 10-K | 001-36156 | 10.33 | 3/1/2023 | |
| 10.14# | 2023 Equity Incentive Plan, as amended | 8-K | 001-36156 | 10.1 | 6/18/2025 | |
| 10.15# | Form of agreements under the 2023 Equity Incentive Plan | 8-K | 001-36156 | 10.2 | 6/9/2023 | |
| 10.16# | Promotion Letter, dated as of August 22, 2023, between John Leite and the Registrant | 10-K | 001-36156 | 10.23 | 2/29/2024 | |
| 10.17# | Change of Control and Severance Agreement, effective September 1, 2023, between John Leite and the Registrant | 10-K | 001-36156 | 10.24 | 2/29/2024 | |
| 10.18# | Offer Letter, dated as of September 11, 2023, between Phil Febbo and the Registrant | 10-K | 001-36156 | 10.25 | 2/29/2024 | |
| 10.19# | Change of Control and Severance Agreement, effective October 2, 2023, between Phil Febbo and the Registrant | 10-K | 001-36156 | 10.26 | 2/29/2024 | |
| 10.20# | 2019 Stock Incentive Plan of C2i Genomics, Inc. | 10-K | 001-36156 | 10.27 | 2/29/2024 | |
| 10.21# | Form of Option Grant under the 2019 Stock Incentive Plan of C2i Genomics, Inc. | 10-K | 001-36156 | 10.28 | 2/29/2024 | |
| 10.22# | Form of Stock Option Assumption Notice by the Registrant to Option holders of C2i Genomics, Inc. | 10-K | 001-36156 | 10.29 | 2/29/2024 | |
| 19. | Insider Trading Policy | 10-K | 001-36156 | 19. | 2/29/2024 | |
| 21.1 | List of Subsidiaries | X | ||||
| 23.1 | Consent of Independent Registered Public Accounting Firm | X | ||||
| 31.1 | Principal Executive Officer’s Certification Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 | X | ||||
| 31.2 | Principal Financial Officer’s Certification Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 | X | ||||
| Incorporated by Reference | ||||||
|---|---|---|---|---|---|---|
| Exhibit Number | Description | Form | File No. | Exhibit | Filing Date | Filed Herewith |
| 32.1* · Certification Pursuant to 18 U.S.C. § 1350 (Section 906 of the Sarbanes-Oxley Act of 2002) · X | ||||||
| 32.2* · Certification Pursuant to 18 U.S.C. § 1350 (Section 906 of the Sarbanes-Oxley Act of 2002) · X | ||||||
| 97.1 | Compensation Recovery Policy | 10-K | 001-36156 | 97.1 | 2/29/2024 | |
| 101.INS | Inline XBRL Instance Document | X | ||||
| 101.SCH | Inline XBRL Taxonomy Extension Schema | X | ||||
| 101.CAL | Inline XBRL Taxonomy Extension Calculation Linkbase | X | ||||
| 101.DEF | Inline XBRL Taxonomy Extension Definition Linkbase | X | ||||
| 101.LAB | Inline XBRL Taxonomy Extension Label Linkbase | X | ||||
| 101.PRE | Inline XBRL Taxonomy Extension Presentation Linkbase | X | ||||
| 104 | Cover Page Interactive Data File (embedded within the Inline XBRL document and included in Exhibit 101) | X | ||||
| # | Indicates management contract or compensatory plan or arrangement. |
|---|---|
| * | In accordance with Item 601(b)(32)(ii) of Regulation S-K and SEC Release No. 34-47986, the certifications furnished in Exhibits 32.1 and 32.2 hereto are deemed to accompany this Form 10-K and will not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934 (the “Exchange Act”) or deemed to be incorporated by reference into any filing under the Exchange Act or the Securities Act of 1933, as amended, except to the extent that the registrant specifically incorporates it by reference. |
| † | Registrant is requesting or has previously been granted confidential treatment with respect to certain portions of this Exhibit. |
Copies of the above exhibits not contained herein are available to any stockholder, upon payment of a reasonable per page fee, upon written request to: Chief Financial Officer, Veracyte, Inc., 6000 Shoreline Court, Suite 300, South San Francisco, California 94080.
(c)Financial Statement Schedules
Reference is made to Item 15(a) 2 above.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.